ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008

Cooperative Groups: Committee Formed To Implement Armitage Report Had A Rough Start

June 12, 1998

Brachytherapy Prevents Endometrial Cancer Return

June 27, 2008

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980